Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1569
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
12523.168
uM
inf
inf
1.0409 1.0409 0.0000 -0.0083
-0.040
0.9035
HCC2185
TNBC
Luminal
FR180204
ERK1/2
MAPK
10996.149
uM
inf
inf
0.9724 0.9724 0.0000 0.0208
0.0401
0.4765
BT-20
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
5902.098
uM
inf
inf
0.9860 0.9860 0.0000 -0.0045
-0.0403
1.1137
BT-20
TNBC
Basal A
Pertuzumab
5903.102
mg/ml
inf
inf
0.9324 0.9324 0.0000 -0.0074
-0.0405
1.2557
T47DKBLUC
Unknown
Unknown
Lapatinib
EGFR/HER2
ErbB
7544.098
uM
inf
inf
0.9586 0.9586 0.0000 0.0541
-0.0405
1.2438
T47DKBLUC
Unknown
Unknown
PD184352
MEK
MAPK
12608.155
uM
inf
inf
0.9291 0.9291 0.0000 0.0321
0.0410
1.1556
T47DKBLUC
Unknown
Unknown
PD184352
MEK
MAPK
12608.155
uM
inf
inf
0.9291 0.9291 0.0000 0.0321
0.0410
1.1556
SUM185PE
TNBC
Luminal
FTase Inhibitor I
Ftase
MAPK
12269.154
uM
inf
inf
0.0944 0.0944 0.0000 0.3950
0.0416
0.9999
MDA-MB-134-VI
HR+
Luminal
PD 98059
MEK
MAPK
10998.152
uM
inf
inf
0.7376 0.7376 0.0000 0.0782
-0.0421
0.8517
MDA-MB-175-VII
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10818.148
uM
inf
inf
0.7403 0.7403 0.0000 0.1474
-0.0425
0.3526
HCC1954
HER2amp
Basal A
Gefitinib
EGFR
ErbB
9386.132
uM
inf
inf
0.7520 0.7520 0.0000 0.1148
0.0425
1.4083
HCC70
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10873.148
uM
inf
inf
0.9161 0.9161 0.0000 0.1719
0.0430
1.2150
MDA-MB-436
TNBC
Basal B
Cetuximab
EGFR
ErbB
7898.018
uM
inf
inf
0.9583 0.9583 0.0000 -0.0243
-0.0431
1.1279
SUM185PE
TNBC
Luminal
Baicalein
Lipoxygenase
Metabolism
12269.072
uM
inf
inf
0.6534 0.6534 0.0000 0.5211
0.0434
1.1256
SUM52PE
HR+
Luminal
Dichloroacetate
PDK
PDK
13570.176
uM
inf
inf
0.7219 0.7219 0.0000 0.3099
0.0434
0.4076
T47DKBLUC
Unknown
Unknown
2-deoxyglucose
13070.177
uM
inf
inf
0.0803 0.0803 0.0000 0.5360
0.0445
0.9040
MDA-MB-468
TNBC
Basal A
Cetuximab
EGFR
ErbB
7905.018
uM
inf
inf
0.5870 0.5870 0.0000 0.1000
-0.0447
0.8988
SK-BR-3
HER2amp
Luminal
Selumetinib
MEK
MAPK
11851.155
uM
inf
inf
0.9361 0.9361 0.0000 0.0510
0.0449
1.5585
MCF 10F
NM
-
Baicalein
Lipoxygenase
Metabolism
12254.072
uM
inf
inf
0.9615 0.9615 0.0000 0.0021
0.0460
1.9429
HCC38
TNBC
Basal B
Cetuximab
EGFR
ErbB
9028.018
uM
inf
inf
0.8573 0.8573 0.0000 0.0500
-0.0461
1.0242
HCC1569
HER2amp
Basal A
AG1024
IGF1R
RTK
7447.066
uM
inf
inf
0.9240 0.9240 0.0000 -0.0284
0.0463
1.5813
MCF 10A
NM
Basal B
PS-1145
IKK
NFKB
7485.065
uM
inf
inf
1.0111 1.0111 0.0000 -0.0094
-0.0465
3.5869
MDA-MB-134-VI
HR+
Luminal
PS-1145
IKK
NFKB
10419.065
uM
inf
inf
1.0047 1.0047 0.0000 0.0356
0.0465
0.7359
MDA-MB-468
TNBC
Basal A
AG1478
EGFR
ErbB
7905.016
uM
inf
inf
1.0500 1.0500 0.0000 0.0810
0.0466
0.6240
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7454.065
uM
inf
inf
0.7779 0.7779 0.0000 0.1159
0.0469
1.0489